SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 188 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $15,605 | +65.1% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $9,450 | +5.5% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $8,960 | +40.7% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $6,370 | -23.9% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $8,370 | -7.5% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $9,050 | -16.0% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $10,770 | +12.9% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $9,540 | -16.9% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $11,480 | -32.3% | 1,000 | 0.0% | 0.00% | -50.0% |
| Q3 2018 | $16,950 | +19.4% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $14,200 | -25.3% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $19,000 | +15.9% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $16,400 | +9.3% | 1,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $15,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alexandria Capital, LLC | 1,003,725 | $15,663,000 | 1.66% |
| Golden State Equity Partners | 123,817 | $1,932,000 | 1.33% |
| Rhenman & Partners Asset Management AB | 821,888 | $12,826,000 | 1.05% |
| WASATCH ADVISORS LP | 10,072,381 | $157,180,000 | 0.77% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 29,636 | $462,000 | 0.73% |
| Ceeto Capital Group, LLC | 80,000 | $1,248,000 | 0.63% |
| EMC Capital Management | 48,992 | $765,000 | 0.58% |
| Fort Sheridan Advisors LLC | 71,173 | $1,111,000 | 0.54% |
| Vanguard Capital Wealth Advisors | 34,680 | $584,000 | 0.54% |
| Casdin Capital, LLC | 1,080,000 | $16,853,000 | 0.50% |